StockWatch
·

Linc Ltd-$ Q2 FY27 Results

LINCQ2 FY27 Results
Filing
Result:Weak· Market: Down#Margin squeeze

Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue154.1210.9%10.8%
Total Income155.3511.4%9.9%
Expenditure147.8712.5%15.6%
PBT7.485.7%44.3%
Net Profit5.2013.9%38.3%
OPM7.34%1.36pp3.93pp
NPM3.35%0.99pp2.62pp
EPS0.7028.6%50.7%
View full financials

Core revenue grew only 10.8% while OPM fell sharply from 11.3% to 7.3%, driving adjusted PAT down 38.3% YoY, a clear margin-led deterioration for this consumer/stationery name.

LINC LTD-$ · QQ2 FY-2027 · THE CALL

Steady growth masked by margin compression; recovery hinges on raw material stabilization

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

12 Nov 2026 · 6 min read
Verdict

Hold

confidence 7/10

Credibility

Grade A

No prior numeric guidance issued; current trajectory aligns with deferred-clarity framework. Facility timeline on track.

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Linc delivered solid double-digit revenue growth (10.8% YoY) and proved execution capability in new categories beyond writing instruments. However, operating margin compressed 390 bps to 7.3% due to geopolitical-driven raw material inflation (190 bps) and elevated sales promotions (200 bps), resulting in PAT declining 38.3% YoY despite top-line strength. Management has flagged near-term RM volatility and deferred clarity on profitability recovery to end-FY27, making the investment case contingent on commodity stabilization and successful West Bengal facility ramp-up.

₹154.1 Cr

Revenue · +10.8% YoY

₹5.2 Cr

Reported PAT · −38.3% YoY

Compressing

Margins · vs guidance: Corroborated

Did the claims hold up?

Management's claims vs. the numbers

Operating income ₹15,412 lakhs with 10.8% YoY growth

MET

Delivered 154.1 Cr (₹15,412 lakhs) exactly; YoY growth 10.8% confirmed

EBITDA ₹1,131 lakhs at 7.3% margin vs 11.3% prior year

MET

Delivered OPM 7.3% matches; prior year at 11.3% (390 bps contraction)

393 bps margin contraction split: 190 bps RM cost + 200 bps sales spend

MET

Attribution adds to 390 bps; accounting is transparent and credible

PAT ₹419 lakhs at 2.7% margin

OVERSTATED

Delivered PAT 5.2 Cr (3.4% margin) vs claimed 4.19 Cr (2.7%). Delivered higher than stated; likely excludes certain items in call.

Raw material mix optimization has cushioned cost impact versus standard SAN/ABS/PP/PC grades

MET

Management cites recent 1-1.5 year RM mix development showing lower cost increases; plausible lever but not quantified

Earnings quality

What changed since the last call

Deltas vs. the prior call

RM cost inflation recognition

New

Prior call deferred clarity on RM trajectory. Q2 confirms geopolitical spikes (190 bps impact) with recent December improvements already visible; management now expects stabilization.

Sales promotion intensity sustained

New

New lever: management explicitly elevated promo spend (200 bps margin drag) to defend market share. Positions growth as share-gaining exercise, not margin-accretive.

West Bengal facility timing reaffirmed

Neutral

Expected Q3 commissioning now confirmed Q4 (end Dec/early Jan). No delay; still on original framework. Framed as operational efficiency gain, not as margin expansion inflection.

Premium segment pivot intensified

Upgrade

New Tri-Tonic drinkware brand and expanded Pentonic portfolio explicitly called out as margin-improvement levers alongside RM mix optimization. Strategic shift beyond writing instruments acknowledged.

The Q&A

Light Q&A with 2-3 substantive questions. Shubhankar pressed on margin recovery timeline—management held to 'volatile' messaging, deferring specifics to end-FY27. Girija questioned West Bengal asset turnover and peer margin gap—answered on facility readiness but sidestepped quantified margin targets. Analysts did not push on sales promo sustainability or PAT decline.

The exchanges that mattered

Margin recovery trajectory — Shubhankar Ojha, participant

Partial

4-6 quarters expected to return to normalized margins if RM prices stabilize. Current situation temporary. Already seeing December improvement. Cannot give exact %, situation volatile; clarity by end-FY27.

Uni-Linc JV product pipeline — Shubhankar Ojha, participant

Answered

One ball pen at ₹20 MRP launched, gaining good distribution. 50%+ of JV revenue from exports. 2 more products in pipeline; 3 total products expected over next 3-4 quarters.

West Bengal facility timeline and margin impact — Girija, participant

Partial

Factory almost set up; commercial production expected end Dec/early Jan (Q4). Facilities ready by Dec. Focused on operational efficiency from modern infra and scope for future expansion. Not envisaging substantial increase in operations initially; shifting old facility to new with integration and expansion scope.

Internal margin improvement levers — Shubhankar Ojha, participant

Answered

Two levers: (1) RM mix optimization developed past 1-1.5 years shows lower cost increases vs standard SAN/ABS/PP/PC grades. (2) Continued focus on premium price-point products (above ₹10) where margins superior to ₹10 price points.

Guidance

Forward guidance and management's confidence

No formal FY27 revenue target; deferred to post-Q2 clarity

Low

Prior guidance framework: focus on categories beyond writing instruments + JV growth. Q2 delivered 10.8% YoY; trajectory suggests mid-to-high single-digit growth sustainable if macro stable.

EBITDA margins expected to recover toward historical 10%+ range over 4-6 quarters

Medium

Conditioned on RM price stabilization. Current 7.3% OPM (vs 11.3% prior year) to improve as input costs ease from Q4 onwards.

West Bengal facility capex near completion; Q4 commissioning; no incremental major capex disclosed

High

Facility modern infrastructure replacing old Kolkata plant; scope for future capacity expansion built in. Near-term capex intensity declining post-commissioning.

Risks the call surfaced

Ranked by how much they should concern a holder

Raw material price volatility

High

Geopolitical uncertainties driving polymer price spikes. 190 bps (₹21.5 Cr annualized EBITDA impact) of Q2 margin pressure directly attributable. Unhedged exposure; RM mix optimization provides some insulation but insufficient buffer.

Sales promotion intensity

Medium

Elevated promotional spending (200 bps margin drag in Q2) deployed to gain market share and support double-digit growth. Unclear if this is temporary growth investment or becomes normalized baseline. If structural, sustainable margin recovery below 10% range.

West Bengal facility execution

Medium

Facility critical for long-term margin recovery and export traction (linked to Morris/Korea subsidiary). Commissioning Q4 FY27 (end Dec/early Jan) now reaffirmed. Management does not anticipate substantial output increase initially; facility is replacement + efficiency + expansion headroom. Risk if ramp-up slower than expected or efficiency gains overstated.

Drinkware/new category margin profile

Low

Tri-Tonic (Tritan-based drinkware) positioned as margin-accretive new category leveraging polymer expertise. Early-stage launch via Stackoo experience centers. Margin profile vs writing instruments not disclosed; execution risk if category scales slower than expected.

JV growth uncertainty

Low

Uni-Linc JV (Mitsubishi Pencil, Japan) contributing 50%+ of its revenue from exports; early-stage product pipeline (3 products over 3-4 quarters). Turkey and Kenya subsidiaries progressing but without quantified upside. Execution risk if JV product launches miss or market adoption slower.

Management

Score 6/10. Clear on operational metrics and challenges (RM inflation quantified, promo spend acknowledged). Cautious on margin recovery timing; deferred specifics to end-FY27. Balanced in tone; avoids over-assertion but also light on concrete forward-year targets. Revenue guidance framework (growth via categories beyond writing instruments + JVs) being met. West Bengal facility on track (Q4 vs prior Q3 guidance). No major misses vs prior-call framework; conservative realism maintained.

What to watch next
  • 1 · Q4 FY27 (Dec 2026 - Jan 2027)

    West Bengal facility commercial production; modern infra to replace old Kolkata plant

  • 2 · Calendar 2027

    Uni-Linc JV: 2 new products launch (₹20 MRP ball pen already live; 2 more planned)

  • 3 · Q3-Q4 FY27

    Raw material prices expected to ease post-December based on geopolitical announcements; margin recovery tailwind

Management has flagged near-term RM volatility and deferred clarity on profitability recovery to end-FY27, making the investment case contingent on commodity stabilization and successful West Bengal facility ramp-up.

Informational and educational content only. Not investment advice.